Blake A. Rowe

A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain

Julie A. O’Brien, Wei Lemaire, Marion Wittmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 172 citations

Medicine, Neuroscience, Pharmacology +17

Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

Lars Lannfelt, Hans Basun, Lars‐Olof Wahlund et al. · Nature Medicine · 1995 · 171 citations

Life Sciences, Neurology, Neuroscience +14

Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2

Hervé Schaffhauser, Blake A. Rowe, Sylvia Morales et al. · Molecular Pharmacology · 2003 · 158 citations

Medicine, Neuroscience, Pharmacology +17

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 107 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

Daniel S. Lorrain, Hervé Schaffhauser, Una C. Campbell et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

Life Sciences, Neurobiology, Neuroscience +9